2021 Annual Meeting | C23 - Frontotemporal Dementias
Program Materials Program Evaluations
01:00 PM - 01:05 PM EDT | Introduction |
Introduction
Elizabeth Finger, MD, FAAN |
01:05 PM - 01:30 PM EDT | Speaker |
Overview and Behavioral Variant Frontotemporal Dementia
Elizabeth Finger, MD, FAAN |
01:30 PM - 01:50 PM EDT | Speaker |
FTD and Primary Progressive Aphasias
Carmela Tartaglia, MD |
01:50 PM - 02:00 PM EDT | Q&A |
Live Questions and Answers
Elizabeth Finger, MD, FAAN, Carmela Tartaglia, MD |
Elizabeth Finger, MD, FAAN | Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. The institution of Dr. Finger has received research support from CIHR. The institution of Dr. Finger has received research support from Physician Servcices Incorporated. The institution of Dr. Finger has received research support from Weston Foundation. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Annual Meeting Course Director with American Academy of Neurology. |
Carmela Tartaglia, MD | Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Tartaglia has received research support from NIH. The institution of Dr. Tartaglia has received research support from University of Toronto. |
Jonathan Graff-Radford, MD, FAAN | Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. |